Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer

Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer

Breast cancer (BC) is the most common malignancy and second only to lung cancer in terms of mortality in women. Despite the incredible progress made in this field, metastatic breast cancer has a poor prognosis. In an era of personalized medicine, there is an urgent need for better knowledge of the b...

Full description

Bibliographic Details
Main Authors: Navid Sobhani, Anna Ianza, Alberto D’Angelo, Giandomenico Roviello, Fabiola Giudici, Marina Bortul, Fabrizio Zanconati, Cristina Bottin, Daniele Generali
Format: Article
Language:English
Published: MDPI AG 2018-07-01
Series:Cells
Subjects:
fibroblast growth factor
fibroblast growth factor receptor
targeted treatments
breast cancer
Online Access:http://www.mdpi.com/2073-4409/7/7/76

Similar Items

Similar Items